Medical Equipment Press Release
|07/07/2020 - 05:43||
Bryant University President Ross Gittell, noted economist and former CCSNH Chancellor, takes office as Bryant's ninth president
SMITHFIELD, RI – (July 7, 2020) Bryant University’s ninth president, Ross Gittell, Ph.D., took office on July 1, ushering in a new era of leadership for the school amid urgent and unprecedented challenges facing higher education. President Gittell previously served as Chancellor of the Community College System of New Hampshire (CCSNH) and is considered one of nation’s preeminent economists and economic development experts.
|Smith and Nephew|
|07/05/2020 - 20:54||
Optim Partners with MedShare to donate ENTity Endoscopes to Underprivileged Communities around the Globe
Optim LLC, a premier manufacturer of proprietary flexible endoscopes for use in the visual diagnosis of Ear-Nose-and-Throat (“ENT”) disorders, announced today it has partnered with MedShare of Decatur, GA to donate the companies ENTity Nasopharyngoscopes to under-served communities around the globe.
|06/30/2020 - 03:11||
Smiths Detection to supply security-screening equipment to Kuwait International Airport
Smiths Detection, a leading threat-detection and security-technology company, will supply hold-baggage screening equipment for Kuwait’s new International Airport Terminal 2, which is currently under construction. The contract includes the installation of HI-SCAN 10080 XCT units for screening hold baggage.
|06/29/2020 - 06:44||
Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx Insertable Cardiac Monitor System
MARLBOROUGH, Mass. , June 29, 2020 / / -- Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the LUX-Dx™ Insertable Cardiac Monitor (ICM) System, a new, long-term diagnostic device implanted in patients to detect arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope.
|06/25/2020 - 09:37||
InspireMD Announces Late-Breaking Presentation of Early SIBERIA Clinical Trial Results to be Featured in an e-Course at EuroPCR
In a head-to-head evaluation, significantly fewer silent brain infarcts were associated with CGuard™ EPS versus Acculink™ at 30 days post-procedure.
|06/25/2020 - 09:19||
Scott Lemos '10, Ph.D.: A career path touched by both Machtley and Gittell
When Scott Lemos ’10, Ph.D. started his academic journey at Bryant University in 2006, he couldn’t have guessed the turns it would take, or that it would be shaped by both Bryant’s retiring President Ronald K. Machtley , and incoming President Ross Gittell, Ph.D.
|Smith and Nephew|
|06/24/2020 - 14:19||
Womens Summit expands the vision of the future
The Bryant University Women’s Summit ® celebrated its 23 rd year of inspiring, empowering, and advancing women on Wednesday, June 10, undaunted by a global pandemic and resolute in support of social justice and inclusion.
|Smith and Nephew|
|06/22/2020 - 12:40||
ISPOR-FDA Summit 2020 on Patient-Preference Information in Medical Devices Is Now Virtual
ISPOR —the professional society for health economics and outcomes research, announced that its joint ISPOR-FDA Summit 2020 has been redesigned as a completely virtual event. The Summit, “Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond,” is jointly sponsored by ISPOR and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH). The virtual event will be held on September 29, 2020. Registration is being offered free of charge for all attendees.
|06/22/2020 - 11:48||
Stockholders Approve Delisting from the Official List
The information required under ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act is attached.
|06/19/2020 - 18:39||
God was watching over me
He had left behind his native Nigeria, where violence and political unrest has long been rampant. Members of his family were murdered there.
|06/19/2020 - 10:46||
Standards Alliance Phase 2 Supports COVID-19 Response and Recovery
In recognition of the importance of standardization and conformity assessment to the global response to the COVID-19 pandemic, the American National Standards Institute (ANSI) is pleased to announce that the Standards Alliance Phase 2 (SA2), as part of its public-private partnership with the United States Agency for International Development (USAID), will specifically address the COVID-19 response and recovery.
|06/19/2020 - 05:44||
Revised ISO 13485 Documentation Kit is re-launched by Global Manager Group
Global Manager Group is revised its product of D126 - ISO 13485:2016 Documentation Kit as per Medical devices - Quality management systems - Requirements...
|Global Manager Group|
|06/17/2020 - 19:03||
Coronavirus (COVID-19) Update: FDA Takes Additional Action to Harness Real-World Data to Inform COVID-19 Response Efforts
Today the U.S. Food and Drug Administration has taken an additional step in harnessing real-world data to help inform the agency’s overall response to the COVID-19 public health emergency. The FDA is announcing its participation in the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project to advance the development of diagnostics. The Diagnostics Evidence Accelerator is organized by the Reagan-Udall Foundation for the FDA in collaboration with Friends of Cancer Research.
|06/17/2020 - 16:41||
Epigenetic Editing Repairs Connections in a Developing Brain Model
MEMPHIS, TN — Le Bonheur Children’s Hospital Endocrinologist Joan C. Han, MD, and researchers at several universities and the National Institutes of Health (NIH) explored whether genetic tools could be used to repair the corpus callosum, the structure connecting the two hemispheres of the brain. When development of the corpus callosum is abnormal, results include disorders such as schizophrenia, intellectual disability and autism spectrum disorder.
|06/17/2020 - 16:29||
AOPEN Announces Heat Finder Thermal Imaging Solution
San Jose, Calif. — AOPEN, a global technology company that specializes in smart products and services for cloud-based applications, is proud to announce the launch of the AOPEN Heat Finder Thermal Imaging Solution – a dual-camera system that quickly and accurately detects elevated body temperatures.
|06/17/2020 - 05:59||
Power Supplies: Five major TDK-Lambda Group sites have obtained certifications of ISO13485 quality management system for medical devices
TDK Corporation is pleased to announce that its subsidiary company, TDK-Lambda Corporation (President: Hiroyuki Yashiro, hereafter TDK-Lambda) Nagaoka Technical Center (Nagaoka City, Niigata Prefecture), received a certification of ISO13485: 2016 *1 Medical devices quality management systems for its quality management system. It is the first among the standard switching power supply manufacturers in Japan.
|06/17/2020 - 02:14||
FDA Approves Apple iMac 27 in Bundle with PerfectLum for Diagnostic Use
QUBYX Medical Solution LLC today announced, that QUBYX received FDA clearance for the Bundle PerfectLum4 with the Apple iMac 27.
|06/16/2020 - 17:59||
Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chembio Antibody Test
Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) of the Chembio Diagnostic System, Inc.
|06/16/2020 - 16:29||
Further Extension of Maturity Date of June 2017 Note & Fundraising Update
Crystal Amber, the Company’s major stockholder, remains supportive of the ongoing financing efforts of the Company. As a result, Crystal Amber has agreed to extend the maturity date of the June 2017 Note from 15 June 2020 to 29 June 2020. This further extension follows the recent extensions announced by the Company on 4 May 2020 and 18 May 2020.
|06/16/2020 - 09:34||
Wearable patch may provide new treatment option for skin cancer
Chi Hwan Lee, a Purdue engineering innovator, developed a wearable patch to provide a new treatment option for skin cancer.
|06/15/2020 - 23:28||
Ophthalmic Device Market will be US$ 67 Billion by 2026
Ophthalmic Device Market is expected to be US$ 67 Billion by the end of the year 2026. According to Renub Research Analysis, the market of Vision Care products will lead the market.
|06/15/2020 - 17:28||
FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD
Today, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital therapeutic device to improve attention function in children with attention deficit hyperactivity disorder (ADHD). The prescription-only game-based device, called EndeavorRx, is indicated for pediatric patients ages 8 to12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.
|06/15/2020 - 09:21||
Richard Staelin, Ph.D. Rejoins the Board of BioElectronics Corporation
FREDERICK, MD, June 15, 2020 ( ) — via NEWMEDIAWIRE – BioElectronics Corporation (OTC: BIEL), www.bielcorp.com , the maker of non-invasive electroceutical devices, announced today that it has appointed Richard Staelin, Ph.D. as the Chairman of the Board following the resignation and retirement of Ms.
|06/15/2020 - 07:07||
GLP-1-Based Treatment of Diabetes Does not Cause Pancreatitis
Diabetes The commonly used treatment for type 2 diabetes and obesity, GLP-1, does not cause pancreatitis. The treatment is known to increase two markers of pancreatitis, but now, a new study shows a harmless, physiological explanation. The finding from the University of Copenhagen can contribute to the safety of diabetes treatment on a global scale.
|06/12/2020 - 00:33||
hIOTron Introduces IoT COVID-19 Contact-Less Body Temperature Monitoring Solution
As all are aware of Coronavirus and its effect on the human body, hence it is necessary to detect symptoms in the initial stage. So here hIOTron is come up with a solution.